Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25247825 | 0.87 | L3MBTL1 (0.36) | L3MBTL1KMT2AMEN1ALDH1A1MAPT | |
| SCHEMBL27138690 | 0.83 | L3MBTL1 (0.32) | L3MBTL1KMT2AMEN1ALDH1A1MAPT | |
| SCHEMBL31662105 | 0.81 | ABCB1 (0.31) | ABCB1 | |
| SCHEMBL30835179 | 0.80 | ABCB1 (0.35) | ABCB1 | |
| SCHEMBL30610877 | 0.78 | PDCD1 (0.31) | — | |
| SCHEMBL30702944 | 0.78 | — | — | |
| SCHEMBL30702909 | 0.78 | FYN (0.35) | KMT2AMEN1ALDH1A1MAPTLMNA | |
| SCHEMBL25401576 | 0.77 | SRC (0.39) | KMT2AMEN1ALDH1A1MAPTRECQL | |
| SCHEMBL26709320 | 0.77 | ABCB1 (0.33) | ABCB1 | |
| SCHEMBL26709236 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025151594-A1 | FUSED AZINES AS RAS INHIBITORS AND METHODS OF USE THEREOF | KESTREL THERAPEUTICS INC. (US) | 2025-07-17 | — | — | WO | disclosed |
| CN-118221700-A | Condensed ring aromatic compound, preparation method and application thereof | 北京华森英诺生物科技有限公司 | 2024-06-21 | — | — | CN | disclosed |